Short-term effects of tetrabenazine in chorea associated with Huntington's disease

被引:0
|
作者
Keaney, C.
Hunter, C.
Davidson, A.
Jankovic, J.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1107
引用
收藏
页码:S635 / S635
页数:1
相关论文
共 50 条
  • [31] Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease
    Heo, Young-A
    Scott, Lesley J.
    DRUGS, 2017, 77 (17) : 1857 - 1864
  • [32] Deutetrabenazine: A Review in Chorea Associated with Huntington’s Disease
    Young-A Heo
    Lesley J. Scott
    Drugs, 2017, 77 : 1857 - 1864
  • [33] Tolerability of tetrabenazine in Huntington's disease
    Jog, M.
    Khandekar, N.
    Attar, A.
    MOVEMENT DISORDERS, 2006, 21 : S357 - S358
  • [34] Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
    Frank, Samuel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 657 - 665
  • [35] Short-term motor effects of riluzole in Huntington's disease: An open-label study
    Granata, R
    Seppi, K
    Mueller, J
    Poewe, W
    Wenning, G
    MOVEMENT DISORDERS, 2002, 17 : S324 - S324
  • [36] Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea
    Fenney, Alison
    Jog, Mandar S.
    Duval, Christian
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (02) : 160 - 167
  • [37] An open label study of tetrabenazine as anti-Chorea therapy in Huntington disease
    Frank, Samuel A.
    NEUROLOGY, 2007, 68 (12) : A365 - A365
  • [38] Tetrabenazine is neuroprotective in Huntington's disease mice
    Wang, Hongyu
    Chen, Xi
    Li, Yuemei
    Tang, Tie-Shan
    Bezprozvanny, Ilya
    MOLECULAR NEURODEGENERATION, 2010, 5
  • [39] Tetrabenazine is neuroprotective in Huntington's disease mice
    Hongyu Wang
    Xi Chen
    Yuemei Li
    Tie-Shan Tang
    Ilya Bezprozvanny
    Molecular Neurodegeneration, 5
  • [40] Management of Huntington's disease: role of tetrabenazine
    de Tommaso, Marina
    Serpino, Claudia
    Sciruicchio, Vittorio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2011, 7 : 123 - 129